Plasma therapy not beneficial in reducing mortality or progression to severe COVID-19: Study

Use of convalescent plasma therapy in coronavirus-infected patients does not help in reducing mortality or progression to severe COVID-19, a multi-centric study funded by the Indian Council of Medical Research (ICMR) has found. The 'open-label parallel-arm phase II multicentre randomized controlled trial' (PLACID Trial) was...